Prof Hope Rugo speaks to ecancer at BGICC 2019 in Cairo about neoadjuvant hormone therapy as a way to treat luminal breast cancer. She discusses some of the key outcomes from the session including some early biological markers of endocrine sensitivity, one being a fall in Ki67, that tends to show